$2.9B worth of the market will need a new solution once regulation is passed and many have already planned ahead and trialled AJX’s product (since AJX is the only alternative solution). I’ve mentioned before that regulatory change is slow as hell but when it does happen how much of that $2.9B will become revenue for AJX? Hint hint, they see FR revenue dwarfing their other chemicals.
So I said this when the yearly was released but if you just add the dollar figures of announced contracts to their revenues, Pegasus plus these 5 new ones is already +17M which takes their annual revenue up to $41M, not including other clients they haven’t announced. I can’t imagine they would still be worth $0.30 per share at that level.
AJX Price at posting:
32.5¢ Sentiment: Buy Disclosure: Held
